Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SYNEOS HEALTH, INC.

(SYNH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/15/2021 06/16/2021 06/17/2021 06/18/2021 06/21/2021 Date
84.6(c) 84.81(c) 85.44(c) 84.64(c) 85.88 Last
737 472 1 648 030 1 388 981 3 421 302 555 639 Volume
+1.35% +0.25% +0.74% -0.94% +1.47% Change
More quotes
Financials (USD)
Sales 2021 5 223 M - -
Net income 2021 231 M - -
Net Debt 2021 2 535 M - -
P/E ratio 2021 38,6x
Yield 2021 -
Sales 2022 5 657 M - -
Net income 2022 332 M - -
Net Debt 2022 2 023 M - -
P/E ratio 2022 26,4x
Yield 2022 -
Capitalization 8 746 M 8 746 M -
EV / Sales 2021 2,16x
EV / Sales 2022 1,90x
Nbr of Employees 24 310
Free-Float 58,7%
More Financials
Company
Syneos Health Inc. is a fully integrated biopharmaceutical solutions providing company. The Company offers both stand-alone and integrated biopharmaceutical product development solutions through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It brings together... 
More about the company
Ratings of Syneos Health, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SYNEOS HEALTH, INC.
08:05aSyneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New ..
GL
06/16SYNEOS HEALTHá : Management Change/Compensation (Form 8-K)
PU
06/16SYNEOS HEALTH, INC.á : Change in Directors or Principal Officers (form 8-K)
AQ
06/16SYNEOS HEALTHá : Dr. David S. Wilkes Appointed to Syneos Health Board of Directo..
AQ
06/12Miners Try to Get Covid-19 Vaccines Into Areas Where Shots Are Scarce
DJ
06/10SYNEOS HEALTHá : SYNH) sees Significant Insider Sales Extending the Trend of Las..
MT
06/10Miners' Efforts to Attract More Female Workers Fall Flat
DJ
06/09INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Syneos Health
MT
06/09INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Syneos Health
MT
06/09INSIDER TRENDS : Insider Prolongs Selling Trend at Syneos Health
MT
06/09INSIDER TRENDS : Insider Sales Extend 90-Day Trend at Syneos Health
MT
06/09INSIDER TRENDS : Selling By Insiders Continues at Syneos Health
MT
06/09INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Syneos Health
MT
06/09INSIDER TRENDS : Insider Extends 90-Day Selling Trend at Syneos Health
MT
06/09INSIDER TRENDS : Syneos Health Insider Continues 90-Day Selling Trend
MT
More news
News in other languages on SYNEOS HEALTH, INC.
06/03Minera rusa Nordgold busca salir a bolsa en Londres y Moscú
More news
Analyst Recommendations on SYNEOS HEALTH, INC.
More recommendations
Chart SYNEOS HEALTH, INC.
Duration : Period :
Syneos Health, Inc. Technical Analysis Chart | SYNH | US87166B1026 | MarketScreener
Technical analysis trends SYNEOS HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Average target price 93,33 $
Last Close Price 84,64 $
Spread / Highest target 25,2%
Spread / Average Target 10,3%
Spread / Lowest Target -29,1%
EPS Revisions
Managers and Directors
NameTitle
Alistair John Macdonald Chief Executive Officer & Director
Jason Michael Meggs Chief Financial Officer & Executive Vice President
John M. Dineen Chairman
Paul D. Colvin President-Clinical Solutions
Larry A Pickett Chief Information & Digital Officer
Sector and Competitors
1st jan.Capitalization (M$)
SYNEOS HEALTH, INC.23.94%8 746
MODERNA, INC.90.67%79 980
LONZA GROUP AG14.63%52 508
IQVIA HOLDINGS INC.33.76%45 934
CELLTRION, INC.-24.79%32 465
SEAGEN INC.-10.75%28 367